Prediction of infarct severity from triiodothyronine levels in patients with ST-elevation myocardial infarction |
Kim, Dong Hun
(Department of Radiology, Chosun University School of Medicine)
Choi, Dong-Hyun (Department of Internal Medicine, Chosun University School of Medicine) Kim, Hyun-Wook (Department of Internal Medicine, Chosun University School of Medicine) Choi, Seo-Won (Department of Internal Medicine, Chosun University School of Medicine) Kim, Bo-Bae (Department of Internal Medicine, Chosun University School of Medicine) Chung, Joong-Wha (Department of Internal Medicine, Chosun University School of Medicine) Koh, Young-Youp (Department of Internal Medicine, Chosun University School of Medicine) Chang, Kyong-Sig (Department of Internal Medicine, Chosun University School of Medicine) Hong, Soon-Pyo (Department of Internal Medicine, Chosun University School of Medicine) |
1 | Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990;16:91-95. DOI |
2 | Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf ) 1993;39:499-518. DOI ScienceOn |
3 | Sypniewski E. Comparative pharmacology of the thyroid hormones. Ann Thorac Surg 1993;56(1 Suppl):S2-S6. DOI |
4 | Opasich C, Pacini F, Ambrosino N, et al. Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J 1996;17:1860-1866. DOI ScienceOn |
5 | Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A, Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 2005;118:132-136. DOI ScienceOn |
6 | Eber B, Schumacher M, Langsteger W, et al. Changes in thyroid hormone parameters after acute myocardial infarction. Cardiology 1995;86:152-156. DOI |
7 | Franklyn JA, Gammage MD, Ramsden DB, Sheppard MC. Thyroid status in patients after acute myocardial infarction. Clin Sci (Lond) 1984;67:585-590. DOI |
8 | Friberg L, Werner S, Eggertsen G, Ahnve S. Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med 2002;162:1388-1394. DOI ScienceOn |
9 | Lymvaios I, Mourouzis I, Cokkinos DV, Dimopoulos MA, Toumanidis ST, Pantos C. Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association? Eur J Endocrinol 2011;165:107-114. DOI ScienceOn |
10 | Klemperer JD, Zelano J, Helm RE, et al. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg 1995;109:457-465. DOI ScienceOn |
11 | Dimitriadis G, Baker B, Marsh H, et al. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol 1985;248(5 Pt 1):E593-E601. |
12 | Lovejoy JC, Smith SR, Bray GA, et al. A paradigm of experimentally induced mild hyperthyroidism: effects on nitrogen balance, body composition, and energy expenditure in healthy young men. J Clin Endocrinol Metab 1997;82:765-770. |
13 | Lebon V, Dufour S, Petersen KF, et al. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest 2001;108:733-737. DOI |
14 | Gomberg-Maitland M, Frishman WH. Thyroid hormone and cardiovascular disease. Am Heart J 1998;135(2 Pt 1):187-196. DOI ScienceOn |
15 | Pantos CI, Malliopoulou VA, Mourouzis IS, et al. Longterm thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid 2002;12:325-329. DOI ScienceOn |
16 | Dyke CM, Yeh T Jr, Lehman JD, et al. Triiodothyronine- enhanced left ventricular function after ischemic injury. Ann Thorac Surg 1991;52:14-19. DOI |
17 | Hsu RB, Huang TS, Chen YS, Chu SH. Effect of triiodothyronine administration in experimental myocardial injury. J Endocrinol Invest 1995;18:702-709. DOI |
18 | Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-1107. DOI ScienceOn |
19 | Mahaffey KW, Raya TE, Pennock GD, Morkin E, Goldman S. Left ventricular performance and remodeling in rabbits after myocardial infarction: effects of a thyroid hormone analogue. Circulation 1995;91:794-801. DOI |
20 | Wu KC. CMR of microvascular obstruction and hemorrhage in myocardial infarction. J Cardiovasc Magn Reson 2012;14:68. DOI |
21 | Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012;5:596-603. |
22 | Kim RJ, Shah DJ. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough. Heart 2004;90:137-140. DOI |
23 | Klem I, Kim RJ. Assessment of microvascular injury after acute myocardial infarction: importance of the area at risk. Nat Clin Pract Cardiovasc Med 2008;5:756-757. DOI ScienceOn |
24 | Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc Imaging 2009;2:825-831. DOI ScienceOn |
25 | Yang HS, Lee CW, Hong MK, et al. Terminal QRS complex distortion on the admission electrocardiogram in anterior acute myocardial infarction and association with residual flow and infarct size after primary angioplasty. Korean J Intern Med 2005;20:21-25. DOI |
26 | Mather AN, Fairbairn TA, Ball SG, Greenwood JP, Plein S. Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart 2011;97:453-459. DOI |
27 | O'Regan DP, Ariff B, Neuwirth C, Tan Y, Durighel G, Cook SA. Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction. Heart 2010;96:1885-1891. DOI ScienceOn |
28 | Tarantini G, Razzolini R, Cacciavillani L, et al. Inf luence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Am J Cardiol 2006;98:1033-1040. DOI ScienceOn |
29 | Baks T, van Geuns RJ, Biagini E, et al. Recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2005;26:1070-1077. DOI ScienceOn |
30 | Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-542. DOI ScienceOn |
31 | Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-1089. DOI ScienceOn |
32 | Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005;26:549-557. DOI |
33 | Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453. DOI ScienceOn |
34 | Pantos C, Dritsas A, Mourouzis I, et al. Thyroid hormone is a critical determinant of myocardial perfor mance in patients with heart failure: potential therapeutic implications. Eur J Endocrinol 2007;157:515-520. DOI ScienceOn |
35 | Friberg L, Drvota V, Bjelak AH, Eggertsen G, Ahnve S. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med 2001;111:699-703. DOI ScienceOn |
36 | Canadian Cardiovascular Society; American Academy of Family Physicians; American College of Cardiology, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;51:210-247. DOI ScienceOn |
37 | Trepanier LA. Medical management of hyperthyroidism. Clin Tech Small Anim Pract 2006;21:22-28. DOI ScienceOn |
38 | Ozcan KS, Osmonov D, Toprak E, et al. Sick euthyroid syndrome is associated with poor prognosis in patients with STEMI undergoing primary percutaneous intervention. Cardiol J 2014 Mar 27 [Epub]. http://dx.doi. org/10.5603/CJ.a2013.0108. |
39 | Pantos C, Mourouzis I, Cokkinos DV. Thyroid hormone and cardiac repair/regeneration: from Prometheus myth to reality? Can J Physiol Pharmacol 2012;90:977-987. DOI ScienceOn |
40 | Pantos C, Mourouzis I, Cokkinos DV. New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev 2011;16:79-96. DOI |
41 | Wiersinga WM. Propranolol and thyroid hormone metabolism. Thyroid 1991;1:273-277. DOI ScienceOn |
![]() |